Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration‐resistant prostate cancer

Liancheng Fan(Shanghai Jiao Tong University), Jiahua Pan(University of Science and Technology of China), Chenfei Chi(Shanghai Jiao Tong University), Rui Wang(Anhui University of Traditional Chinese Medicine), Yan Yang(Second Military Medical University), Yiming Gong(Chongqing University), Baijun Dong(Shanghai Jiao Tong University), Hongying Zheng(Shanghai Jiao Tong University), Xiaowei Ma(Shanghai Jiao Tong University), Yinjie Zhu(Shanghai Jiao Tong University)
The Prostate
January 6, 2019
10.1002/pros.23762
Cited by 13

Related Papers

Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation
|Cell Reports|2023|161
Characteristics and Workload of Pediatricians in China
|PEDIATRICS|2019|107
Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma
|Frontiers in Endocrinology|2022|81
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer
|Nature Cancer|2022|71
Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing
|The Journal of Urology|2020|36